Most Read Articles
Elvira Manzano, 22 Jan 2018
A new study has shown an independent association between periodontal disease and incident stroke risk. What’s interesting is routine dental care can attenuate the stroke risk.
Audrey Abella, 17 Dec 2018
Low rates of cardiovascular (CV) or major bleeding complications were observed among octogenarians who were receiving active NOAC* therapy, suggesting that long-term anticoagulation with NOACs may result in a good risk-benefit ratio in this patient subgroup, according to data presented at ASH 2018.
Pank Jit Sin, 01 Feb 2019
Single pill combination (SPC) therapy is increasingly accepted and helps to overcome some of the problems associated with multipharmacy and compliance, says an expert. 
Rachel Soon, 31 Jan 2019

More home blood pressure (BP) and office BP measurements should be encouraged to identify otherwise hidden cases of hypertension, said an expert.

Statins have no effect on immature platelet count in CAD patients

09 Oct 2018

The use of statins does not appear to influence the immature platelet count in patients with coronary artery disease (CAD), a new study has shown.

Researchers enrolled 642 CAD patients undergoing coronary angiography, from whom blood samples were drawn upon admission and subjected to standard biochemical and blood cell count methods. Multiple logistic regression analyses were employed to determine the relationship between immature platelet count (IPC) and the use of statins.

Of the participants, 61.2 percent (n=393; mean age 68.4±9.7 years; 80.7 percent male) were on statin medication upon study admission while the remaining 38.8 percent were not (n=249; mean age 68.2±11.5 years; 73.9 percent male). Atorvastatin was the most frequently used statin (60.8 percent).

While the metabolic profile of statin-treated patients was worse (glycated haemoglobin: p=0.007; high-density lipoprotein cholesterol: p=0.005; low-density lipoprotein cholesterol: p<0.001 ), mean IPC concentration did not significantly differ between treated and nontreated participants (7.9±4.7 vs 7.7±5 x106/mL; p=0.60).

Baseline statin use likewise had no effect on the distribution of patients across IPC tertiles: tertile 1 (31 percent vs 36.1 percent), tertile 2 (34.6 percent vs 30.5 percent) and tertile 3 (34.4 percent vs 33.3 percent; p=0.36).

These findings were further validated by multivariate regression, which showed that statin use was not significantly correlated with the rate of IPC 8.4 106/mL (adjusted odds ratio, 1.19; 95 percent CI, 0.80–1.79; p=0.39).

Moreover, in 190 patients who were initiated on statin therapy upon discharge, the IPC levels at 32 days of follow-up were statistically comparable to those who were already on statin medication at study admission.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 22 Jan 2018
A new study has shown an independent association between periodontal disease and incident stroke risk. What’s interesting is routine dental care can attenuate the stroke risk.
Audrey Abella, 17 Dec 2018
Low rates of cardiovascular (CV) or major bleeding complications were observed among octogenarians who were receiving active NOAC* therapy, suggesting that long-term anticoagulation with NOACs may result in a good risk-benefit ratio in this patient subgroup, according to data presented at ASH 2018.
Pank Jit Sin, 01 Feb 2019
Single pill combination (SPC) therapy is increasingly accepted and helps to overcome some of the problems associated with multipharmacy and compliance, says an expert. 
Rachel Soon, 31 Jan 2019

More home blood pressure (BP) and office BP measurements should be encouraged to identify otherwise hidden cases of hypertension, said an expert.